Proteomic analysis reveals that Adh1p is involved in a synergistic fluconazole and tetrandrine mechanism against Candida albicans

By Zhang Xiao-Li   Zhang Ge-Hua   Wang Zhi-Yuan   Guo Hui   Gao Lai-Qiang   Wu Si   Song Yan-Jun   Zhang Hong  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 12, 2013-12 ,pp. : 951-954

Govi-Verlag

Access to resources Recommend Favorite

Effective concentration-based serum pharmacodynamics for antifungal azoles in a murine model of disseminated Candida albicans infection

By Maki Katsuyuki   Kaneko Shuji  

European Journal of Drug Metabolism and Pharmacokinetics, Vol. 38, Iss. 4, 2013-12 ,pp. : 261-268

Springer Publishing Company

Access to resources Recommend Favorite

Candida albicans experimental infection: effects on human sperm motility, mitochondrial membrane potential and apoptosis

By Burrello Nunziatina   Salmeri Mario   Perdichizzi Anna   Bellanca Salvatore   Pettinato Giuseppe   D'Agata Rosario   Vicari Enzo   Calogero Aldo E  

Reproductive BioMedicine Online, Vol. 18, Iss. 4, 2009-04 ,pp. : 496-501

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Novel small molecules for the treatment of infections caused by Candida albicans: a patent review (2002 –– 2010)

By Calugi Chiara   Trabocchi Andrea   Guarna Antonio  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 3, 2011-03 ,pp. : 381-397

Informa Healthcare

Access to resources Recommend Favorite

Molecular mechanisms underlying the tetrandrine-mediated reversal of the fluconazole resistance of Candida albicans

By Zhang Xiaoli   Guo Hui   Gao Laiqiang   Song Yanjun   Li Shuixiu   Zhang Hong  

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 51, Iss. 6, 2013-06 ,pp. : 749-752

Informa Healthcare

Access to resources Recommend Favorite